5.7 Artificial intelligence (AI) in diagnosis and monitoring AI and machine learning (ML) are revolutionizing PD management through: Early diagnosis : analyzing digital biomarkers (e.g., voice, gait, handwriting)
For example, wild-type p53 replacement therapy, although widely studied and used, is unable to repair or eliminate aberrant genes and is often considered insufficiently effective in clinical practice
Singh, I., Lal, M., Khanna, P
Naltrexone combined with bupropion is approved for chronic weight management in certain adults
Intravenous therapy is gaining popularity as a complementary treatment for chronic disorders